Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON, Boston Research Institute in Strategic Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News

ICON, Boston Research Institute in Strategic Alliance

ICON has entered a strategic alliance with Boston Clinical Research Institute (BCRI), an Academic Research Organization.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON has entered a strategic alliance with Boston Clinical Research Institute (BCRI), an Academic Research Organization. The alliance will combine BCRI’s leadership in clinical strategy, study planning and academic relationships with ICON’s experience in the execution of global clinical trials.

BCRI provides scientific consultancy in study design using expert clinicians and key opinion leaders from premier medical institutions, and also maintains a network of global investigators in all of the medical specialties and subspecialties.

“We are extremely pleased to announce the partnership with ICON,” said Dr. Michael Gibson, founder and senior consultant at BCRI. “We believe that the future of clinical research is collaboration between the ARO and the CRO. ICON clearly recognizes the incremental benefits of collaboration with the thought leaders in the medical community to optimize study planning, execution, and credibility.”

Peter Gray, chief executive officer at ICON, said, “We are delighted that Dr. Gibson and BCRI have aligned with ICON. The relationship provides ICON and its clients with access to a breadth of expertise in the key opinion leader community and to investigators worldwide, including national and international leaders. Anticipated benefits include enhanced planning, design, site selection and enrolment performance.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics